Full Press Release Details
BridgeBio Pharma Grows Pipeline To 20+ Genetic Medicines With Four Assets Focused On Treating Genetically Driven Diseases At Their Source.
BBIO
BridgeBio Pharma Grows Pipeline To 20+ Genetic Medicines With Four Assets Focused On Treating Genetically Driven Diseases At Their Source
Key Takeaway: BridgeBio Pharma Grows Pipeline To 20+ Genetic Medicines With Four Assets Focused On Treating Genetically Driven Diseases At Their Source